findmyKOL

Scott Tagawa, MD

Enriched profile

Professor of Medicine and Professor of Medicine in Urology; Gebroe Family Professor of Hematology-Oncology; Director, Genitourinary Oncology Program · Weill Cornell Medicine

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 New York, NY · Northeast · United StatesSpecialtyHematology / OncologyFocusProstate Cancer+9
Active KOLfindmyKOL type: NationalLatest publication2026Online presenceverified 2026Payments2021–2025NIH funding2024–2026

Scott Tagawa is Professor of Medicine and Professor of Medicine in Urology; Gebroe Family Professor of Hematology-Oncology; Director, Genitourinary Oncology Program at Weill Cornell Medicine. OpenAlex indexes 825 publications with 27,220 citations (h-index 71); ClinicalTrials.gov lists 16 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Hematology / Oncology profiles in the findmyKOL directory.

Data verified 7 Sept 2026

Overview

Updated 16 Oct 2026

Scott Tagawa, MD, is Professor of Medicine and Professor of Medicine in Urology at Weill Cornell Medicine (NewYork-Presbyterian – Weill Cornell Medical Center). The public record shows 825 publications with 27,220 citations (h-index 71), centered on Prostate Cancer, Kidney Cancer / RCC, Breast Cancer. It also documents an investigator role on 16 registered clinical trials, industry payments reported by 36 companies, 1 NIH-funded awards (2024–2026).

  • Most recent indexed publication: 2026 · Science advances
  • Top research focus: Prostate Cancer
  • 16 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 36 companies

Generated from the cited public record · current as of 16 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Prostate Cancer14 trialsKidney Cancer / RCC2 trialsBreast Cancer1 trialLung Cancer (NSCLC/SCLC)1 trialColorectal Cancer1 trialPancreatic Cancer1 trialGastroesophageal Cancer1 trialOvarian / Gynecologic Cancer1 trialHead & Neck Cancer1 trialNeuro-Oncology / Glioma1 trialRectal Neoplasms1 trialEsophageal Neoplasms1 trialGlioma1 trialSmall Cell Lung Carcinoma1 trialKidney Neoplasms1 trialProstatic Neoplasms, Castration-Resistant1 trial

Research focus

OpenAlex concept fingerprint
Prostate CancerKidney Cancer / RCCBreast CancerColorectal CancerGastroesophageal CancerHead & Neck CancerLung Cancer (NSCLC/SCLC)Neuro-Oncology / GliomaOvarian / Gynecologic CancerPancreatic Cancer

Drugs & molecules

across trials, industry payments and publications
Xtandigeneric · EnzalutamideClinical trials—Industry payments31Publications5Trodelvygeneric · SacituzumabClinical trials—Industry payments14Publications5Keytrudageneric · PembrolizumabClinical trials—Industry payments9Publications3Lynparzageneric · OlaparibClinical trials—Industry payments9Publications2Padcevgeneric · EnfortumabClinical trials—Industry payments2Publications1GozetotideClinical trials—Industry payments76Publications—Orgovyxgeneric · RelugolixClinical trials—Industry payments24Publications—Erleadageneric · ApalutamideClinical trials—Industry payments17Publications—Talzennageneric · TalazoparibClinical trials—Industry payments17Publications—PiflufolastatClinical trials—Industry payments13Publications—Pluvictogeneric · Vipivotide tetraxetanClinical trials—Industry payments12Publications—Cabometyxgeneric · CabozantinibClinical trials—Industry payments11Publications—

Works with

trial sponsors and companies reporting payments
Telix PharmaceuticalsClinical trials—Industry payments47Pfizer Inc.Clinical trials—Industry payments42Merck Sharp & Dohme LLCClinical trials—Industry payments35Novartis Pharmaceuticals CorporationClinical trials—Industry payments24Gilead Sciences, Inc.Clinical trials—Industry payments21AstraZeneca Pharmaceuticals LPClinical trials—Industry payments15Progenics Pharmaceuticals, Inc.Clinical trials—Industry payments13Lantheus Medical Imaging, Inc.Clinical trials—Industry payments12Weill Medical College of Cornell UniversityClinical trials12Industry payments—Exelixis Inc.Clinical trials—Industry payments11Genzyme CorporationClinical trials—Industry payments10Janssen Biotech, Inc.Clinical trials—Industry payments10Regeneron Pharmaceuticals, Inc.Clinical trials—Industry payments8Ge HealthcareClinical trials—Industry payments7Bayer HealthCare Pharmaceuticals Inc.Clinical trials—Industry payments6Janssen Scientific Affairs, LLCClinical trials—Industry payments6Abbvie Inc.Clinical trials—Industry payments5Daiichi Sankyo Inc.Clinical trials—Industry payments4Janssen Global Services, LLCClinical trials—Industry payments4Edap Technomed IncClinical trials—Industry payments3Janssen Research & Development, LLCClinical trials—Industry payments3Amgen Inc.Clinical trials—Industry payments2AngioDynamics, Inc.Clinical trials—Industry payments2Astellas Pharma US IncClinical trials—Industry payments2Eli Lilly and CompanyClinical trials—Industry payments2EMD Serono, Inc.Clinical trials—Industry payments2Blue Earth Diagnostics LimitedClinical trials—Industry payments1Boston Scientific CorporationClinical trials—Industry payments1Clarity Pharmaceuticals LtdClinical trials1Industry payments—Clovis Oncology, Inc.Clinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
825publications

Distinct works indexed by OpenAlex, matched via ORCID; 58 in PubMed.

27,220citations

Total citations across indexed works.

71h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
16clinical trials

Investigator role on registered studies.

View trials ↓
36companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
1NIH grants · 2024–2026

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 16 Oct 2026

Listed as an investigator on 16 registered studies on ClinicalTrials.gov. The most recent:

All 16 trial records: search, sort and filter.Explore →

Industry payments

Updated 16 Oct 2026

36 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

All 68 payment records: search, sort and filter.Explore →
View the CMS Open Payments record ↗

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Metabolism & gastrointestinal

    55.6%
    Corticosteroid55.6%
    Prednisone100%
    Part D<11 patients

  • Nervous system

    44.4%
    Gabapentinoids44.4%
    Gabapentin100%
    Part D<11 patients
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 16 Oct 2026

1 NIH research award on record, funded 2024–2026 per NIH RePORTER. The latest:

All 5 award records: search, sort and filter.Explore →

Publications

Updated 16 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

All 58 publications: search, sort and filter.Explore →

Online presence

Updated 16 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/scott-tagawa-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
  • ResearchGate

    researchgate.net/profile/Scott-Tagawa

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
  • X / Twitter

    x.com/drscotttagawa

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →x.com ↗
  • LinkedIn

    linkedin.com/in/scott-tagawa-2868a115

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗

Mentions by others

where others cite or feature them
  • Facebook

    facebook.com/OncLive/videos/scott-t-tagawa-md-ms-facp-fasco-of-weill-cornell-medicine-details-factors-to-con/1521201145733828

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →facebook.com ↗
  • Other

    nyp.org/advances/podcast/phase-3-trial-reduces-risk-of-progression-in-metastatic-prostate-cancer

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nyp.org ↗
  • Other

    prostatehealthpodcast.com/56-prostate-specific-membrane-antigen-psma-targeting-in-prostate-cancer-treatment-scott-tagawa-m-d

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →prostatehealthpodcast.com ↗
  • YouTube

    youtube.com/watch

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 16 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • M.S. in Clinical Investigation

    Weill Cornell Graduate School of Medical Sciences

    2010
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →weillcornell.org ↗
  • M.D.

    University of Southern California School of Medicine

    1998
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →weillcornell.org ↗
  • B.S.

    Georgetown University

    1993
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →weillcornell.org ↗
  • Board Certified

    American Board of Internal Medicine (Internal Medicine, Hematology, and Medical Oncology)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →weillcornell.org ↗
  • FACP (Fellow, American College of Physicians); FASCO (Fellow, American Society of Clinical Oncology)
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →weillcornell.org ↗

Editorial & leadership roles

journal and society appointments

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.